Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: a Mendelian Randomisation study (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2022.04.27.22273667
Publication URI: http://dx.doi.org/10.1101/2022.04.27.22273667
Type: Preprint